2023
In the field of skin inflammation, plant series products are listed: 7 varieties, covering the skin, oral and nasal health services
2022
Obtaining capital investment, the first batch of two plant products in Jiangsu Province successfully passed the record (Xiaozi 2 Hufu Hunong brand: skin antibacterial liquid, skin antibacterial gel)
2021
Established Shenzhen joint venture company, currently canceled
2020
Start the research and development of plant series products in the field of skin inflammation
2019
Investigation and Exploratory Research of Plant Products in the Field of Skin Inflammation
2018
Technology transfer project anti-blood tumor drug lenalidomide raw materials and its capsules, the transferee party Yangzijiang Pharmaceuticals obtained chemical 4 drug production number 2.
2017
Obtain 7 clinical approvals for drug tablets and 3 raw materials.
2015
Set up a small molecule drug pharmacy research and development team, build a small test and pilot sample preparation laboratory, under the drug synthesis department, drug analysis and quality research department, solid preparation department, project management department and project project department.
2014
Set up a small molecule drug pharmacy research and development team, build a small test and pilot sample preparation laboratory, under the drug synthesis department, drug analysis and quality research department, solid preparation department, project management department and project project department.